Outset Medical, Inc. (OM) Revenue, Earnings & Financial Statements
$3.16NMS: OMMarket Cap $59.57M
Data as of Nov 17, 2026 close · Statements through the quarter ended Jun 2026 · Source: Financial Modeling Prep (methodology)
Outset Medical, Inc. most recently reported annual revenue of $119.0M, a net loss of $82.0M. Revenue grew at an average annual rate of 18.9% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Outset Medical, Inc.: Revenue rose from $2.0M in 2018 to $119.0M in 2025, a change of +5850.0% over 7 years; net profit was positive in 0 of 8 reported years; operating margin moved from -2320.0% to -55.8%, a shift of +2264.2 percentage points; the most recent year shows a net loss of $82.0M.
Income Statement — 8 Years (USD millions)
Metric
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
$2.0M
$15.0M
$50.0M
$103.0M
$115.0M
$130.0M
$114.0M
$119.0M
Operating Expenses
$49.0M
$85.0M
$167.0M
$233.0M
$276.0M
$300.0M
$227.0M
$186.0M
Operating Profit
−$47.0M
−$70.0M
−$117.0M
−$131.0M
−$161.0M
−$170.0M
−$113.0M
−$67.0M
Operating Margin
-2320.0%
-466.3%
-235.2%
-127.2%
-139.6%
-130.2%
-99.7%
-55.8%
Other Income
−$3.0M
$2.0M
−$4.0M
−$1.0M
−$2.0M
−$3.0M
−$14.0M
−$14.0M
Interest
$5.0M
$4.0M
$3.0M
$2.0M
$4.0M
$13.0M
$24.0M
$14.0M
Depreciation
$1.0M
$2.0M
$3.0M
$5.0M
$5.0M
$6.0M
$6.0M
$4.0M
Profit Before Tax
−$50.0M
−$68.0M
−$121.0M
−$132.0M
−$163.0M
−$172.0M
−$127.0M
−$81.0M
Tax rate (%)
-0.1%
-0.0%
0.0%
-0.1%
-0.2%
-0.3%
-0.4%
-0.9%
Net Profit
−$50.0M
−$68.0M
−$121.0M
−$132.0M
−$163.0M
−$173.0M
−$128.0M
−$82.0M
EPS
−$1.65
−$34.06
−$2.83
−$43.41
−$50.75
−$52.27
−$36.95
−$5.37
Quarterly Results — Last 12 Quarters (USD millions)
8 duplicate period labels in the source data were collapsed.
Metric
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue
$30.0M
$31.0M
$28.0M
$27.0M
$29.0M
$29.0M
$30.0M
$31.0M
$29.0M
$29.0M
$28.0M
$32.0M
Operating Expenses
$76.0M
$68.0M
$65.0M
$58.0M
$53.0M
$51.0M
$46.0M
$48.0M
$45.0M
$47.0M
$45.0M
$47.0M
Operating Profit
−$45.0M
−$37.0M
−$37.0M
−$31.0M
−$24.0M
−$22.0M
−$16.0M
−$17.0M
−$16.0M
−$18.0M
−$17.0M
−$16.0M
Operating Margin
-149.7%
-122.4%
-131.0%
-112.3%
-83.2%
-74.2%
-55.1%
-53.7%
-53.7%
-61.0%
-60.7%
-49.5%
Interest
$3.0M
$3.0M
$6.0M
$6.0M
$6.0M
$6.0M
$4.0M
$3.0M
$3.0M
$3.0M
$3.0M
$3.0M
Profit Before Tax
−$46.0M
−$38.0M
−$40.0M
−$34.0M
−$28.0M
−$26.0M
−$26.0M
−$18.0M
−$17.0M
−$19.0M
−$19.0M
−$18.0M
Tax rate (%)
-0.2%
-0.3%
-0.4%
-0.4%
-0.7%
0.0%
-0.5%
-0.6%
-2.3%
-0.5%
-1.2%
-1.2%
Net Profit
−$46.0M
−$39.0M
−$40.0M
−$34.0M
−$28.0M
−$26.0M
−$26.0M
−$19.0M
−$18.0M
−$19.0M
−$19.0M
−$18.0M
EPS
−$0.93
−$0.77
−$11.77
−$9.96
−$8.30
−$7.35
−$7.44
−$1.04
−$1.00
−$1.09
−$1.03
−$0.97
Over the 8 years reported for Outset Medical, Inc., borrowings increased from $29.0M in 2018 to $101.0M in 2025, cash stood at $35.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 6.61 times.
Balance Sheet — 8 Years (USD millions)
Metric
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
$151.0M
$88.0M
$404.0M
$463.0M
$400.0M
$314.0M
$276.0M
$264.0M
Current Assets
$148.0M
$80.0M
$346.0M
$410.0M
$374.0M
$291.0M
$258.0M
$251.0M
Cash
$33.0M
$37.0M
$295.0M
$182.0M
$73.0M
$69.0M
$124.0M
$35.0M
Inventory
$3.0M
$5.0M
$18.0M
$39.0M
$51.0M
$49.0M
$59.0M
$48.0M
Receivables
$1.0M
$4.0M
$6.0M
$26.0M
$28.0M
$33.0M
$36.0M
$28.0M
Fixed Assets
$3.0M
$8.0M
$23.0M
$20.0M
$22.0M
$19.0M
$12.0M
$9.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
$0
$0
Investments
$110.0M
$34.0M
$20.0M
$190.0M
$218.0M
$135.0M
$38.0M
$138.0M
Other Assets
$0
$0
$0
$0
$0
$0
$0
$0
Total Liabilities
$439.0M
$461.0M
$75.0M
$89.0M
$154.0M
$191.0M
$249.0M
$138.0M
Current Liabilities
$10.0M
$25.0M
$37.0M
$52.0M
$52.0M
$55.0M
$45.0M
$38.0M
Borrowings
$29.0M
$29.0M
$39.0M
$38.0M
$103.0M
$136.0M
$202.0M
$101.0M
Other Liabilities
$410.0M
$431.0M
$37.0M
$52.0M
$51.0M
$55.0M
$47.0M
$36.0M
Equity
$0
$0
$0
$0
$0
$0
$0
$0
Reserves
−$288.0M
−$372.0M
$329.0M
$374.0M
$246.0M
$123.0M
$27.0M
$127.0M
For Outset Medical, Inc., operating cash flow was positive in 0 of 8 reported years; free cash flow in the latest year was negative at $47.0M; free cash flow was positive in 0 of 8 years.
Cash Flow Statement — 8 Years (USD millions)
Metric
2018
2019
2020
2021
2022
2023
2024
2025
Operating Cash Flow
−$46.0M
−$70.0M
−$99.0M
−$130.0M
−$146.0M
−$131.0M
−$116.0M
−$46.0M
Investing Cash Flow
−$138.0M
$71.0M
−$5.0M
−$146.0M
−$75.0M
$80.0M
$103.0M
−$98.0M
Financing Cash Flow
$0
$0
$5.0M
$11.0M
$0
$0
−$1.0M
$0
Net Cash Flow
$20.0M
$4.0M
$291.0M
−$113.0M
−$139.0M
−$5.0M
$56.0M
−$89.0M
Free Cash Flow
−$48.0M
−$74.0M
−$108.0M
−$133.0M
−$154.0M
−$135.0M
−$117.0M
−$47.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
-0.02
EV / EBITDA
-2.55
FCF Yield
-59.11%
Quick Ratio
5.34
Interest Coverage
-4.79
Return 1Y
-23.88%
Return 3Y
-94.99%
Return 5Y
-99.45%
Outset Medical, Inc. (OM) financials — frequently asked questions
What is Outset Medical, Inc.'s annual revenue?
Outset Medical, Inc. (OM) reported annual revenue of $119.0M in its most recent fiscal year.
What is Outset Medical, Inc.'s net profit?
Outset Medical, Inc. (OM) reported a net loss of $82.0M in its most recent fiscal year.
What is OM EV/EBITDA?
Outset Medical, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -2.55. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.
Revenue and earnings of other Medical - Devices stocks